Rational development of LEA29Y (belatacept), a high-affinity variant of CTLA4-Ig with potent immunosuppressive properties
- Christian P. Larsen
- , Thomas C. Pearson
- , Andrew B. Adams
- , Paul Tso
- , Nozomu Shirasugi
- , Elizabeth Strobert
- , Dan Anderson
- , Shannon Cowan
- , Karen Price
- , Joseph Naemura
- , John Emswiler
- , Jo Anne Greene
- , Lori Ann Turk
- , Jurgen Bajorath
- , Robert Townsend
- , David Hagerty
- , Peter S. Linsley
- , Robert J. Peach
Research output: Contribution to journal › Article › peer-review
690
Link opens in a new tab
Scopus
citations